Emerging Immunotherapy Approaches for Treating Prostate Cancer

被引:10
|
作者
Meng, Lingbin [1 ]
Yang, Yuanquan [1 ]
Mortazavi, Amir [1 ]
Zhang, Jingsong [2 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
immunotherapy; prostate cancer; immune checkpoint inhibitors; bispecific antibodies; CAR T cells; vaccines; cytokines; immunotherapeutic combinations; CAR-T-CELLS; IMMUNE-CHECKPOINT; DOUBLE-BLIND; PHASE-III; PLUS DOCETAXEL; CLINICAL-TRIAL; SIPULEUCEL-T; TUMOR MICROENVIRONMENT; DNA VACCINE; ANTIGEN;
D O I
10.3390/ijms241814347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunotherapy has emerged as an important approach for cancer treatment, but its clinical efficacy has been limited in prostate cancer compared to other malignancies. This review summarizes key immunotherapy strategies under evaluation for prostate cancer, including immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines. For each modality, the rationale stemming from preclinical studies is discussed along with outcomes from completed clinical trials and strategies to improve clinical efficacy that are being tested in ongoing clinical trials. Imperative endeavors include biomarker discovery for patient selection, deciphering resistance mechanisms, refining cellular therapies such as CAR T cells, and early-stage intervention were reviewed. These ongoing efforts instill optimism that immunotherapy may eventually deliver significant clinical benefits and expand treatment options for patients with advanced prostate cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Immunology and immunotherapy approaches for prostate cancer
    E Elkord
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 224 - 236
  • [2] Immunology and immunotherapy approaches for prostate cancer
    Elkord, E.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (03) : 224 - 236
  • [3] Approaches Used in Immunotherapy for Prostate Cancer
    Sonpavde, Guru
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (04) : 238 - 244
  • [4] Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy
    Antonarakis, Emmanuel S.
    Drake, Charles G.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 258 - 265
  • [5] Editorial: Emerging engineering approaches in cancer immunotherapy
    Xu, Jialu
    Ming, Xin
    Min, Yuanzeng
    Wang, Chao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Current and emerging trends in prostate cancer immunotherapy
    Schatz, Adam
    Mian, Badar M.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (01): : 6 - 11
  • [7] Immunotherapy for Prostate Cancer: An Emerging Treatment Modality
    Drake, Charles G.
    UROLOGIC CLINICS OF NORTH AMERICA, 2010, 37 (01) : 121 - +
  • [8] The Current and Emerging Role of Immunotherapy in Prostate Cancer
    Madan, Ravi A.
    Gulley, James L.
    CLINICAL GENITOURINARY CANCER, 2010, 8 (01) : 10 - 16
  • [9] Emerging role of immunotherapy in the management of prostate cancer
    Slovin, Susan F.
    ONCOLOGY-NEW YORK, 2007, 21 (03): : 326 - 333
  • [10] Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches
    Cha, Edward
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27) : 3677 - 3685